We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma Control Study 2011

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01298739
First Posted: February 18, 2011
Last Update Posted: October 25, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
AstraZeneca
  Purpose
Asthma control study 2011

Condition
Asthma Control Level

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Asthma Control Study 2011

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Asthma control level [ Time Frame: 2 times ]

Secondary Outcome Measures:
  • Routine Therapeutical habits in control maintenance [ Time Frame: 2 time ]

Enrollment: 1524
Study Start Date: February 2011
Study Completion Date: October 2011
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Asthmatic patients above 18 y
Criteria

Inclusion Criteria:

  • Asthmatic patients above 18 y

Exclusion Criteria:

  • COPD
  • pulmonary cancer
  • pulmonary tuberculosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298739


  Show 53 Study Locations
Sponsors and Collaborators
AstraZeneca
Investigators
Principal Investigator: György Losonczy, MD PHD Semmelweis University Budapest Pulmonology Clinic
  More Information

Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01298739     History of Changes
Other Study ID Numbers: NIS-RHU-XXX-2011/1
First Submitted: February 16, 2011
First Posted: February 18, 2011
Last Update Posted: October 25, 2011
Last Verified: October 2011

Keywords provided by AstraZeneca:
asthma control level , ACQ

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases